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OBJECTIVE — Todeterminetheprevalenceandriskfactorsforurinaryincontinenceamong
different racial/ethnic groups of overweight and obese women with type 2 diabetes.
RESEARCH DESIGN AND METHODS — Cross-sectional analysis of baseline data
from the Action for Health in Diabetes (Look AHEAD) study, a randomized clinical trial with
2,994 overweight/obese women with type 2 diabetes.
RESULTS — Weekly incontinence (27%) was reported more often than other diabetes-
associatedcomplications,includingretinopathy(7.5%),microalbuminuria(2.2%),andneurop-
athy (1.5%). The prevalence of weekly incontinence was highest among non-Hispanic whites
(32%) and lowest among African Americans (18%), and Asians (12%) (P  0.001). Asian and
African American women had lower odds of weekly incontinence compared with non-Hispanic
whites (75 and 55% lower, respectively; P  0.001). Women with a BMI of 35 kg/m
2 had a
higher odds of overall and stress incontinence (55–85% higher; P  0.03) compared with that
for nonobese women. Risk factors for overall incontinence, as well as for stress and urgency
incontinence,includedpriorhysterectomy(40–80%increasedrisk;P0.01)andurinarytract
infection in the prior year (55–90% increased risk; P  0.001).
CONCLUSIONS — Among overweight and obese women with type 2 diabetes, urinary
incontinence is highly prevalent and far exceeds the prevalence of other diabetes complications.
Racial/ethnic differences in incontinence prevalence are similar to those in women without
diabetes, affecting non-Hispanic whites more than Asians and African Americans. Increasing
obesity (BMI 35 kg/m
2) was the strongest modiﬁable risk factor for overall incontinence and
stress incontinence in this diverse cohort.
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U
rinary incontinence is a highly
prevalentconditionaffectingnearly
50% of middle-aged and older
women (1,2). It can result in psychologi-
cal stress and social isolation and can also
have a profound effect on quality of life
(1). Increasing weight is associated with
urinary incontinence (3), most likely be-
cause of increasing pressure on the blad-
der and straining the muscles that
supporttheurethra(4).Otherriskfactors
for incontinence include increasing age,
parity, and prior hysterectomy (5).
Onegroupathighriskfordeveloping
urinary incontinence is women with type
2 diabetes. Recent epidemiological evi-
dence suggests that incontinence is asso-
ciated with type 2 diabetes and is 50–
200%morecommonamongwomenwith
type 2 diabetes than among women with
normal glucose levels (6,7). A likely etiol-
ogy for incontinence in diabetes is micro-
vascular damage, similar to the disease
process involved in development of reti-
nopathy, nephropathy, and neuropathy
(8).Accordingly,durationofdiabetes(9),
insulin treatment (6), peripheral neurop-
athy, and retinopathy (9) have been sug-
gested as risk factors for incontinence
among women with diabetes. However,
few studies have examined both the prev-
alenceandriskfactorsforoverallandtype
of incontinence (urgency and stress in-
continence) among different racial/ethnic
groups of women with type 2 diabetes.
We conducted a cross-sectional anal-
ysis using data from the Action for Health
in Diabetes (Look AHEAD) study to ex-
amine the prevalence of incontinence,
overall and by type, in a large sample of
overweight and obese women with type 2
diabetes from diverse racial/ethnic
groups. We also determined risk factors
associated with weekly incontinence epi-
sodes both overall and by type (stress and
urgency).
RESEARCH DESIGN AND
METHODS— The Look AHEAD
study was started in 2001 with planned
follow-up until 2012 (10). This random-
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obese individuals with type 2 diabetes is
assessing the long-term effects of an in-
tensive weight loss program delivered
over 4 years versus those of a control di-
abetes support and education program.
The primary aim is to study the effects of
thetwointerventionsonmajorcardiovas-
cularevents:heartattack,stroke,andcar-
diovascular-related death. Secondary
aims include investigating the impact of
the interventions on diabetes control and
complications, ﬁtness, general health,
health-related quality of life, and psycho-
logical outcomes. Individuals were re-
cruited from a variety of sources
including informational mailings, open
screenings, advertisements, and referrals
from health care providers. The study is
being conducted in 16 clinical centers in
theU.S.Eligibilitycriteriawereage45–74
years, which was changed to 55–74 years
during year 2 to increase the anticipated
cardiovascular event rate, and BMI 25
kg/m
2 (27 kg/m
2, if individuals were
currently taking insulin). Major exclu-
sions included A1C 11%, blood pres-
sure 160/100 mmHg, triglycerides
600 mg/dl, inadequate control of co-
morbid conditions, factors that may limit
adherencetotheintervention,andunder-
lying disease likely to limit life span
and/or affect safety of the interventions.
Informed consent was obtained from all
participants before screening, consistent
with the Declaration of Helsinki and the
guidelines of each center’s institutional
review board.
Data collection
Urinary incontinence. Urinary inconti-
nence was assessed by a series of detailed
self-reported questions modiﬁed from
validated questions used in previous
studies (11–13). Frequency of inconti-
nence was assessed by the question, “In
thepast12months,haveyouleakedeven
asmallamountofurine?”(none,lessthan
once per month, one or more times per
month, one or more times per week, or
every day). Women with weekly inconti-
nence in the last year were also asked to
recall the type and number of inconti-
nence episodes in the past 7 days. Ques-
tions to determine type of incontinence
episodes included the following: “. . . how
many times did you leak urine with . . .”
“. . . an activity like coughing, sneezing,
lifting,orexercise?”(stressincontinence),
“. . . an urge to urinate and couldn’t get to
the bathroom fast enough?” (urgency in-
continence), and “. . . other reasons or
don’t know” (other incontinence). The
predominant type of incontinence was
coded based on whether a participant re-
portedahigherfrequencyofweeklystress
or urgency incontinence episodes. Mixed
incontinence was coded when the fre-
quencies of each type of incontinence ep-
isode were reported as equal.
Demographicdataandmedicalhistory.
Standardized interviewer-administered
questionnaires were used to obtain self-
reported data on age, ethnicity, meno-
pausal status, number of urinary tract
infections in the past year, oral estrogen
use, parity, prior hysterectomy, claudica-
tion (i.e., “do you get pain in either leg on
walking?”), chronic medical illnesses
(history of myocardial infarction, stroke,
coronary artery bypass graft [CABG], or
percutaneous transluminal coronary an-
gioplasty [PTCA]), arthritis, liver disease
(i.e., “has a doctor or other health pro-
vider ever said that you have liver dis-
ease?”), emphysema or asthma, sleep
apnea (i.e., “have you ever been told by a
doctor that you had sleep apnea?”), alco-
hol consumption (drinks per week),
smoking history (never, former, or cur-
rent), and overall health status (excellent,
good, fair, poor, or very poor). For the
latter question, participants who rated
their health status as fair, poor, or very
poor were categorized as having poor
overall health. Depressive symptoms
weremeasuredusingtheBeckDepression
Inventory, which has been validated in
other studies (14).
Anthropometry and blood pressure.
Certiﬁed clinic staff obtained measure-
mentsofbodysize.Weightwasmeasured
in duplicate on a digital scale. Standing
heightwasdeterminedinduplicatewitha
standardstadiometer.BMIwascalculated
as weight in kilograms divided by the
square of height in meters. Waist circum-
ference was measured with subjects in
light clothing with a nonmetallic, con-
stant-tension tape placed around the
body at the midpoint between the highest
point of the iliac crest and lowest part of
the costal margin in the midaxillary line.
Seated blood pressure was measured in
duplicate after rest using an automated
device.
Cardiorespiratory ﬁtness. All partici-
pants completed a maximal graded exer-
cise test to determine cardiorespiratory
ﬁtness. The test consisted of the partici-
pant walking on a motorized treadmill at
self-selected walking speeds with a 1.0%
increase in grade every minute until test
termination. Termination of the test oc-
curred at the point of volitional exhaus-
tion or at the point at which medical
contraindications were observed (e.g.,
S-T segment changes or inappropriate
blood pressure response). The level of ﬁt-
ness was deﬁned as the maximal METs
achieved, estimated from a standard for-
mulathatincorporateswalkingspeedand
maximal grade of the treadmill achieved
during the test (15,16).
Serum measures. Blood samples were
collected and processed at baseline ac-
cording to the Look AHEAD protocol
(17). Whole-blood samples for A1C anal-
ysis were measured by the Look AHEAD
Central Biochemistry Laboratory (North-
westLipidResearchLaboratories,Univer-
sity of Washington, Seattle, WA) using a
dedicated ion-exchange high-perfor-
mance liquid chromatography instru-
ment (Bio-Rad Variant II).
Diabetes treatments and complications.
Diabetes medication and insulin use were
obtained by self-report and veriﬁed by
having participants bring their prescrip-
tion medications to the clinic. Peripheral
neuropathy was assessed using the 15-
item Michigan Neuropathy Screening In-
strument, which has been validated in
previous studies (18); the self-reported
presence of 6 symptoms (e.g., numb-
ing, burning, or soreness) was coded as
neuropathy.Albuminandcreatininecon-
centrations were measured from spot
urine samples, and microalbuminuria
was deﬁned as an albumin-to-creatinine
ratio 30.0 g/mg. Retinopathy was as-
sessed using a standard self-reported
question (i.e., being told by a physician
that diabetes had affected the eye).
Statistical analysis
All analyses were performed using SAS
(version 9.1; SAS Institute, Cary, NC). Bi-
variate relationships between potential
risk factors and the prevalence of urinary
incontinence were assessed with 
2 tests
for categorical variables and Student’s t
tests for continuous variables. Logistic re-
gression with a backward elimination
variableselectionmethodwasusedtoob-
tain a subset of risk factors that had inde-
pendent (P  0.10) relations with weekly
or more frequent urinary incontinence.
Then, the same procedure was used to
separately select risk factors for weekly or
more frequent (versus less than weekly)
stress incontinence and weekly or more
frequent (versus less than weekly) ur-
gency incontinence. No analyses were
conducted for mixed incontinence be-
cause of the limited number of partici-
Risk factors for urinary incontinence
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included as a covariate. Waist circumfer-
ence and BMI were highly correlated (r 
0.70). However, results were similar
when waist circumference and BMI were
entered in separate models or simulta-
neously; here we report results from the
simultaneous models. Other predictors
were not strongly intercorrelated (gener-
ally, r  0.40), indicating limited col-
linearity. Interactions between race and
each of the other risk factors were exam-
ined. Results are presented as odds ratios
(ORs) and 95% CIs.
We chose weekly or more frequent
incontinent episodes as our primary out-
come because of the clinical signiﬁcance
of this factor and use in previous research
(6). We selected less than weekly as the
referencegroup,whichincludedlessthan
monthly, monthly, and no incontinence
episodes. We performed additional anal-
ysestoinvestigatewhetherdifferinglevels
of incontinence (none, less than monthly,
monthly, or weekly) were associated with
similar risk factors. In general, increasing
frequency of incontinence was associated
with worsening risk factor values. Be-
cause similar risk factors were identiﬁed
in analyses using different reference
groups (i.e., monthly, less than monthly,
or none), here we only present results
from the multivariate logistic regression
modelsusingweeklyormorefrequentin-
continence as the outcome and the com-
bined less than weekly incontinence as
the reference group.
RESULTS— Of the total of 5,145 par-
ticipants enrolled in Look AHEAD, 3,063
(59.5%) were women. We excluded 29
women who did not answer the urinary
incontinence self-reported questions and
40 women who answered that they had
weekly incontinence in the last year but
none in the last week, leaving a total of
2,994 women for our analysis. The
mean  SD age of participants in the an-
alytic sample was 58.0  6.8 years (range
45–76 years).
AmongwomeninLookAHEAD,27%
reported at least weekly incontinence
with 11% reporting daily episodes (Table
1). The prevalence of weekly inconti-
nence was highest among non-Hispanic
white (32%) followed by American Indi-
an/Alaskan Native (31%), Hispanic
(22%), African American (18%), and
Asian (12%) women (P  0.001). Of the
women with incontinence symptoms in
thepastweek,396(52%)reportedstress-
predominant incontinence, 298 (39%)
reported urgency-predominant inconti-
nence, and 64 (8%) reported an equal
number of stress and urgency inconti-
nence episodes. Fifty-four women were
unable to be classiﬁed because of incom-
plete responses.
Women with weekly incontinence
differed signiﬁcantly from women with-
out incontinence in several ways (Table
2). Incontinent women were more obese,
had higher BMI and waist circumfer-
ences, and had lower average ﬁtness lev-
els. They were more likely to be
postmenopausal, to have reported a prior
hysterectomy, and to be current users of
oral estrogen therapy. They were older
and reported worse overall health, more
frequent urinary tract infections, higher
Beck Depression Inventory scores, and
more frequent history of claudication, ar-
thritis,liverdisease,asthma,andsleepap-
nea; they were also more likely to be
current or former smokers. There was lit-
tle difference between women with and
without urinary incontinence with re-
spect to parity, blood pressure, or history
of myocardial infarction, stroke, CABG,
or PTCA.
Inthismiddle-agedandoldertrialco-
hortofoverweightandobesewomenwith
type 2 diabetes, retinopathy (7.5%) was
the most prevalent diabetes-associated
complication, followed by microalbu-
minuria (albumin-to-creatinine ratio
30 g/mg [2.2%]) and peripheral neu-
ropathy (1.5%) (Table 2). Fewer women
with incontinence had retinopathy (P 
0.03), but there was little difference be-
tween women with and without urinary
incontinence with respect to neuropathy,
microalbuminuria, diabetes duration, di-
abetes control, or diabetes treatment
regimen.
Risk factors for urinary incontinence
overall, as well as for stress and urgency
urinary incontinence, were examined in
separate stepwise multivariable logistic
regression models. In all three models,
non-Hispanic white ethnicity, prior hys-
terectomy, and 1 urinary tract infection
in the past year signiﬁcantly increased the
odds of weekly or more frequent inconti-
nence (Table 3). Speciﬁcally, compared
with non-Hispanic whites, African Amer-
ican women had a 55–70% lower odds of
overall weekly incontinence and inconti-
nence by both types. Prior hysterectomy
wasrelatedtoa40–80%increaseinodds
of incontinence, and urinary tract infec-
tionsinthepastyearwereassociatedwith
a 55–90% increase in odds of
incontinence.
For weekly or more overall inconti-
nence, women with BMI of 35–39 kg/m
2
(OR 1.65 [95% CI 1.20–2.28]) and 40
kg/m
2 (1.84 [1.32–2.55]) had higher
odds of incontinence than less obese
women, with similar ﬁndings for stress
incontinence. Other risk factors associ-
ated with weekly or more overall inconti-
nence and stress incontinence but not
urgency incontinence included liver dis-
ease, higher Beck Depression Inventory
scores, and more alcoholic drinks per
week.
Risk factors for overall incontinence
and urgency incontinence included age
70 years (two- to threefold increased
odds), sleep apnea (55–85% increased
Table 1—Frequency of urinary incontinence in the past year by race/ethnicity among women with type 2 diabetes at baseline: Look AHEAD
trial
Urinary incontinence
frequency
Non-Hispanic
white
African
American Hispanic
Native American/
Alaskan Native Asian Mixed/other* Total
n 1,635 595 466 201 33 64
Daily 209 (13) 42 (7) 56 (12) 24 (12) 0 (0) 13 (20) 344 (11)
Weekly 306 (19) 64 (11) 46 (10) 38 (19) 4 (12) 10 (16) 468 (16)
Monthly 331 (20) 104 (17) 73 (16) 32 (16) 7 (21) 11 (17) 558 (19)
1 per month 402 (25) 119 (20) 75 (16) 41 (20) 10 (30) 13 (20) 660 (22)
None 387 (24) 266 (45) 216 (46) 66 (33) 12 (36) 17 (27) 964 (32)
Data are n (%). N  2,994. *Includes 6 women who did not report race/ethnicity.
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Weekly incontinence*
Less than weekly or
no incontinence P
n 812 2,182
Age (years) 58.5  6.9 57.7  6.7 0.01
Race/ethnicity 0.001
Non-Hispanic white 515 (64) 1,120 (51)
African American 106 (13) 489 (22)
Hispanic 102 (13) 364 (17)
Native American/Alaskan Native 62 (8) 139 (6)
Asian/Paciﬁc Islander 4 (0) 29 (1)
Other 23 (3) 41 (2)
BMI (kg/m
2) 37.5  6.4 36.1  5.9 0.001
BMI 0.001
30 kg/m
2 91 (11) 324 (15)
30 to 35 kg/m
2 222 (27) 731 (34)
35 to 40 kg/m
2 252 (31) 613 (28)
40 kg/m
2 247 (30) 513 (24)
Waist circumference (cm) 112.8  13.7 110.1  13.3 0.001
Systolic blood pressure (mmHg) 129.0  17.8 129.0  17.5 0.93
Diastolic blood pressure (mmHg) 67.2  9.1 68.5  9.5 0.01
Maximal ﬁtness (METs) 6.46 (1.63) 6.76 (1.69) 0.001
Beck Depression Inventory 7.1  5.5 5.8  4.9 0.001
Parity 0.11
0 97 (12) 320 (15)
1 112 (14) 319 (15)
2 587 (74) 1,506 (70)
Postmenopausal status 684 (89) 1,774 (85) 0.01
Hysterectomy 361 (45) 821 (38) 0.001
Current oral estrogen use 226 (28) 523 (25) 0.03
Diabetes duration (years) 6.6  6.9 6.6  6.4 0.81
Therapy for diabetes 0.63
Diet-controlled only 110 (14) 296 (14)
Oral medication only 543 (68) 1,427 (66)
Current insulin use 146 (18) 426 (20)
Retinopathy 47 (6) 177 (8) 0.03
Peripheral neuropathy† 17 (2) 29 (1) 0.13
A1C (%) 7.2  1.1 7.3  1.2 0.06
Albumin-to-creatinine ratio 30 g/mg 20 (3) 45 (2) 0.48
Urinary tract infections in past year 0.001
None 650 (82) 1,901 (88)
1–2 104 (13) 220 (10)
3 34 (4) 36 (2)
Myocardial infarction 25 (3) 69 (3) 0.91
Stroke 24 (3) 47 (2) 0.20
CABG or PTCA 36 (4) 93 (4) 0.83
Claudication 164 (20) 341 (16) 0.01
Arthritis 397 (49) 944 (43) 0.01
Liver disease 44 (5) 66 (3) 0.01
Emphysema 13 (2) 18 (1) 0.06
Asthma 81 (10) 140 (6) 0.001
Sleep apnea 86 (11) 139 (6) 0.001
Overall health status 0.03
Excellent/very good 203 (25) 634 (29)
Good 423 (52) 1,121 (52)
Fair/poor 183 (23) 415 (19)
Ever smoker 379 (47) 856 (39) 0.001
Alcoholic drinks per week 0.8  2.2 0.6  1.7 0.01
Dataaren(%)ormeansSD.N2,994.*Weeklyincontinence:urinaryincontinencedeﬁnedas1incontinentepisodeperweek.†Peripheralneuropathydeﬁned
as 6 self-reported symptoms on the Michigan Neuropathy Screening Instrument (18).
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and ever smoker (25–65% increased
odds). Other risk factors for urgency-
predominant incontinence included poor
overall health (50% increased odds) and
increasing waist circumference (2% in-
creased odds per unit increase).
To identify factors associated with in-
continence that differed in African Amer-
ican, non-Hispanic white, American
Indian/Alaskan Natives, and Hispanic
women, we examined interactions be-
tween race and each predictor variable,
adjusting for clinic site. No interaction
reachedtheP0.05levelofsigniﬁcance.
CONCLUSIONS— Among middle-
aged and older overweight and obese
women with type 2 diabetes who volun-
teered to participate in the Look AHEAD
clinical trial, we found urinary inconti-
nence to be highly prevalent with 27%
reportingweeklyormorefrequentincon-
tinence. Incontinence was far more prev-
alent than other commonly recognized
diabetes-associatedcomplicationssuchas
retinopathy (7.5%), microalbuminuria
(2.2%), and neuropathy (1.5%). Al-
though women in this trial were volun-
teers, the prevalence of incontinence in
this sample was similar to that in other
population-based studies among women
withdiabetes(19)andhigherthanamong
women without diabetes (5).
In this racially/ethnically diverse clin-
ical trial cohort, we found that non-
Hispanic white women had the highest
rates of weekly urinary incontinence and
prevalence was lowest among African
Table 3—Factors signiﬁcantly associated with overall and type of incontinence
Overall Stress Urgency
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Factors associated with overall, stress, and
urgency incontinence
Race/ethnicity (ref.  white) 0.001 0.001 0.009
African American/black 0.44 (0.33–0.58) 0.30 (0.19–0.46) 0.44 (0.28–0.67)
American Indian/Alaskan Native 0.51 (0.15–1.76) 0.36 (0.06–2.12) 0.52 (0.07–3.85)
Asian 0.26 (0.06–1.14) 0.47 (0.11–2.10) NA*
Hispanic 0.76 (0.52–1.11) 0.98 (0.61–1.56) 0.61 (0.32–1.17)
Other/multiple 0.93 (0.49–1.76) 0.93 (0.41–2.09) 0.90 (0.36–2.29)
Urinary tract infections (1 in past year) 1.55 (1.20–2.02) 0.001 1.57 (1.12–2.18) 0.008 1.91 (1.31–2.79) 0.001
Hysterectomy (ref.  none) 1.42 (1.17–1.73) 0.001 1.38 (1.07–1.77) 0.01 1.83 (1.36–2.45) 0.001
Factors associated with overall and/or stress
incontinence
BMI (ref.  30 kg/m
2) 0.001 0.03
30–34 kg/m
2 1.17 (0.85–1.61) 1.12 (0.74–1.69)
35–39 kg/m
2 1.65 (1.20–2.28) 1.56 (1.03–2.36)
40 kg/m
2 1.84 (1.32–2.55) 1.64 (1.07–2.51)
Liver disease (ref.  none) 1.54 (0.99–2.40) 0.06 1.92 (1.13–3.24) 0.02
Beck Depression Inventory 1.04 (1.02–1.06) 0.001 1.04 (1.01–1.06) 0.002
Alcoholic drinks per week 1.06 (1.00–1.12) 0.04 1.08 (1.01–1.15) 0.03
Claudication (ref.  none) 1.32 (0.97–1.80) 0.08
Factors associated with overall and/or urgency
incontinence
Age (ref.  50 years)
50–54 years 1.32 (0.90–1.94) 0.07 0.94 (0.49–1.80) 0.008
55–59 years 1.46 (1.05–2.04) 1.53 (0.89–2.63)
60–64 years 1.34 (0.94–1.92) 1.67 (0.95–2.94)
65–69 years 1.45 (0.96–2.18) 1.59 (0.83–3.04)
70 years 2.12 (1.31–3.43) 3.22 (1.59–6.54)
Sleep apnea (ref.  none) 1.55 (1.12–2.15) 0.008 1.85 (1.17–2.93) 0.009
Asthma (ref.  none) 1.45 (1.03–2.04) 0.03 1.61 (0.98–2.64) 0.06
Smoking (ever; ref.  never) 1.27 (1.05–1.54) 0.01 1.65 (1.24–2.20) 0.001
Diastolic blood pressure 0.99 (0.98–1.00) 0.06 0.99 (0.97–1.00) 0.08
Retinopathy (ref.  none) 0.40 (0.19–0.86) 0.02
Overall health status (ref.  excellent/very
good) 0.05
Good 1.49 (1.05–2.12)
Fair/poor 1.63 (1.03–2.56)
Waist circumference (cm) 1.02 (1.01–1.03) 0.004
ORs and 95% CIs are derived from three separate backwards selection logistic regression models to select a subset of risk factors that had independent (P  0.10)
relations with weekly or more urinary incontinence and then separately for weekly or more stress and urgency incontinence, with adjustment for clinic site. *NA,
not applicable: number of cases of urgency incontinence too small for estimation for Asian women. Ref., reference.
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continence overall and by type. The ob-
served prevalence of 18% among African
American women with type 2 diabetes in
this clinical trial sample was similar to
rates observed among African American
women without diabetes and in popula-
tion-based samples (2,5). In studies of
women without diabetes, African Ameri-
can women have been shown to have
greater pelvic muscle bulk and urethral
sphincter strength relative to those in
non-Hispanic white women, and this dif-
ference may explain why, even among
obese women with diabetes, African
American women have lower rates of in-
continence and a lower risk for inconti-
nence(20).Otherresearchhasfoundthat
waist circumference values are substan-
tially lower in African American than in
non-Hispanic white women (21), and
higher waist-to-hip ratio is an indepen-
dent predictor of incontinence in women
(22). Although waist circumference and
race did not signiﬁcantly interact in pre-
dictingurinaryincontinenceinourstudy,
AfricanAmericanshadsigniﬁcantlylower
waistcircumferencethanwhites(datanot
shown). Thus, it is possible that differ-
ences in body shape or amount of visceral
adipose tissue could further explain the
reducedprevalenceofincontinenceinAf-
rican American than in non-Hispanic
white women.
Importantly, we found that increas-
ing weight (BMI 35 kg/m
2) was associ-
ated with increased risk of overall
incontinence and stress incontinence. Al-
though this effect was not observed in
comparingwomenwithBMIsbetween25
and 30 kg/m
2, this trial did not include
normal-weight individuals; so, it is un-
clear whether the risk of incontinence
wouldbegreaterinwomenwithBMIsbe-
tween 25 and 35 kg/m
2 compared with
those of normal weight. In a sample of
patients from Kaiser Permanente, Law-
rence et al. (23) examined associations
between incontinence and diabetes, with
or without obesity, using a reference
group consisting of overweight and nor-
mal-weight women without diabetes. In-
terestingly, among women with diabetes,
being obese (BMI 30 kg/m
2) was asso-
ciated with an increased risk of stress in-
continence compared with being
nonobese. Also, diabetes was related to
increased risk both with or without obe-
sity. Although obesity and diabetes may
beindependentmodiﬁableriskfactorsfor
incontinence,futureresearchisneededto
further examine the threshold above
which body weight increases risk in dia-
betic women; such information is critical
to informing future targets for treatment
and prevention intervention.
Obesity and abdominal fat, in partic-
ular, may inﬂuence urinary incontinence
byincreasingpressureonthebladderand
straining the muscles and connective tis-
sue that support the urethra (4). Whether
these mechanisms would apply to over-
weight remains unclear. The strong posi-
tive relationship between obesity and
insulin resistance (24) suggests several
other potential mechanisms linking obe-
sity/overweight and incontinence. We
will be able to determine in the Look
AHEAD trial whether weight loss among
overweight and obese women with type 2
diabetes results in decreased urinary in-
continence, overall and by type. A recent
randomized controlled trial demon-
strated a signiﬁcant decrease in urinary
incontinence among overweight and
obese women enrolled in a lifestyle inter-
vention (25).
Interestingly, we did not ﬁnd a rela-
tionship between diabetes-speciﬁc com-
plications such as peripheral neuropathy,
microalbuminuria, duration of diabetes,
and A1C and risk of incontinence. Other
studieshavereportedsimilarﬁndings(9).
It is possible that increasing weight may
have confounded detection of effects of
these measures on incontinence in this
obese population. In addition, diabetes
complications were uncommon in this
self-selected cohort. Thus, it is possible
that sampling factors may have prevented
detection of relationships between diabe-
tes complications and incontinence.
Our study participants were clinical
trial volunteers who were overweight and
obese with type 2 diabetes, so prevalence
estimates might not be similar in popula-
tion-based samples of overweight/obese
women with type 2 diabetes or in women
who are not overweight/obese or who do
not have diabetes. Because individuals
withfunctionallimitationswereexcluded
from the study, “healthier” diabetic sub-
jects may be overrepresented in this sam-
ple. However, we have no reason to
believe that the risk factors that we have
identiﬁed would not be similar in other
groups of women. Furthermore, because
this study was cross-sectional, we could
not examine more powerful longitudinal
associations to identify the temporal se-
quence of the onset of various conditions.
Urinary incontinence information was
based on self-report. However, the reli-
ability and validity of self-reported incon-
tinence has been demonstrated in
previous studies (11). In addition, assess-
ment of retinopathy was based on self-
report instead of more objective
photographic assessments. Finally, only
waist circumference and not waist-to-hip
ratio was assessed in this study.
In summary, urinary incontinence is
highly prevalent among overweight and
obese women with type 2 diabetes in the
LookAHEADtrial.Importantly,theprev-
alence of incontinence in this sample far
exceeds that of other commonly recog-
nized diabetes-associated complications
such as retinopathy, microalbuminuria,
andneuropathy.Racial/ethnicdifferences
in incontinence prevalence are similar to
those observed among women without
diabetes, with non-Hispanic white
women being affected more than other
groups and African American women
less. Physicians should be alert for incon-
tinence among women with type 2 diabe-
tes. Data from the Look AHEAD trial will
determine whether weight loss has an im-
pact on reducing urinary incontinence
among women with type 2 diabetes.
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